Feb 07, 2025 / 10:00AM GMT
Cecilia de Leeuw - C Rad AB - Chief Executive Officer
Welcome to our Q4 presentation. We closed the year with growing order intake and solid profitability. But let me first zoom out briefly and take you through C-RAD's long term strategy and our progress for Q4 and 2024.
As most of you already know, C-RAD is active within radiation therapy, and more than half of all cancer patients undergo radiation therapy at some point of their treatment. So let me take you through this slide from left to right.
First, we have a market leading patient centric portfolio integrated with all leading Linac proton and CT suppliers. And I'm proud that we have over 1900 systems supplied globally.
Secondly, we have a global reach and are expanding step by step. And in the fourth quarter, we have successfully broadened our base of installations in a EMEA and that is visible in the 112% revenue growth in Q4.
Thirdly, C-RAD sees an untapped potential in both advanced and developing markets which we want to capture.
And also, for this quarter, we had us retrofit wins on variant Linux.
Q4 2024 C Rad AB Earnings Call Transcript
Feb 07, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers